Dr. Lonie S. Haynes

Renowned for his professionalism and expertise in building platforms for diversity, Dr. Lonie S. Haynes DLP, MSc, MPA, ACHE has excelled as the senior vice president and global chief diversity and inclusion officer at the AmerisourceBergen Corporation since 2020. In this role, he has addressed the needs of employees and patients in relation to the disproportionate impact of COVID-19 on communities of color, as well as offered transformational discussions following the murder of George Floyd, along with numerous other initiatives. In addition, he has also been a guest lecturer and visiting fellow at New York University since 2020.

Prior to his current roles, Dr. Haynes was the founding partner and principal of RD – Raison d’etre Consultancy from 2019 to 2020. For eight years, beginning in 2012, he served Highmark Health as vice president of diversity and inclusion, spending his final year with the company as chief diversity officer. Likewise, he was a senior manager of diversity affairs, manager of network support and service delivery project manager for AT&T from 2002 to 2011. In his first professional role, Dr. Haynes was an applications consultant and diversity manager for Sprint from 1999 to 2001.

Abundantly educated, Dr. Haynes earned a Bachelor’s degree in political science and business from the State University of New York at Albany and a Master of Science in business administration and management from Boston University in 2009. In 2012, he attained a Doctor of Law and Policy from Northeastern University in 2012, as well as a Master of Public Administration from the City University of New York, Baruch College. Notably, Dr. Haynes earlier served as a specialist E-4, rising to the rank of lieutenant, in the U.S. Army and National Guard.  

To remain abreast of his industry, Dr. Haynes maintains professional affiliation with the American College of Healthcare Executives, National Association of Health Services Executives, National Black MBA Association and 100 Black Men of America. In addition, he served as a member of the board of directors to the American Association of People with Disabilities and to TBrexa BioSciences Inc., a privately held, preclinical biopharmaceutical company. Looking toward the future, Dr. Haynes aims to continue to expand his university teaching and lecturing, along with consulting around health disparities.